CrowdStrike vs. UiPath: Which Technology Stock Is a Better Buy in 2026?

The more useful distinction is not “AI winner” versus “AI loser,” but whether each platform retains a durable control point as AI changes software workflows. CRWD has the stronger security-spend tailwind: more AI-generated activity expands the attack surface and can support security budgets. But at the article’s cited valuation, that thesis is already priced for sustained execution; any growth or margin disappointment can compress the multiple disproportionately. Its reported cash generation also deserves a quality haircut until SBC-adjusted cash conversion is assessed. AMZN’s infrastructure relationship may support workload demand, but it also creates concentration exposure rather than a clean, incremental AMZN earnings catalyst.

PATH is the contrarian setup, not an uncomplicated value buy. LLMs and platform vendors could commoditize basic automation, while agent governance, orchestration, and complex deployments could make PATH more—not less—valuable. The deciding evidence is customer expansion and renewal behavior, not headline AI partnerships or GAAP profitability alone. CRM’s agent offerings raise substitution risk; SNOW integration could help PATH reach governed data workflows, but does not establish material revenue contribution.

Near term, valuation and earnings revisions likely dominate. Over 1–3 months, monitor CRWD subscription/ARR growth, operating leverage, and SBC-adjusted cash conversion; for PATH, watch net retention, recurring-revenue growth, and evidence that AI features increase expansion rather than replace existing licenses. Over 6–18 months, durable AI-agent monetization could rerate PATH, while weak renewals would validate the disruption discount. The source’s valuation figures are snapshots, not a reliable standalone comparison; verify current multiples and normalized earnings before sizing.